ArticleEuropean burn journal2024
26 Years of Skin Banking in Finland.
Article in European burn journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Autologous skin grafts are the gold standard for definitive wound coverage in burn care, but allograft skin grafts are essential for providing temporary coverage in cases of extensive burns. The Helsinki Skin Bank, established in 1995 at the Helsinki Burn Centre, is Finland's only licensed skin bank, serving a population of 5.5 million. It procures human skin allografts from multi-organ donors in the Greater Helsinki area and preserves them using glycerol, a method pioneered by the Euro Skin Bank. Between 2009 and 2020, the Helsinki Skin Bank procured skin from 263 donors and provided allografts to 248 patients, primarily burn victims. Over time, procurement methods have improved significantly, resulting in an increase in the amount of skin harvested per donor. Despite rising costs due to more stringent European Union regulations and the need for round-the-clock operations, the bank has remained cost-effective. The glycerol preservation method ensures microbiological safety and effective storage, with minimal contamination issues. The future may see advances in skin substitutes and stem cell treatments, but for now, allogenic skin remains crucial in burn care due to its availability, ease of use, and cost-efficiency. Running a small, professional skin bank for a single burn center has proven successful and sustainable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.